Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting

Advanced Pharmaceutical Bulletin - Tập 9 Số 2 - Trang 195-204
Unnati Garg1, Swati Chauhan1, Upendra Nagaich1, Neha Jain1,2
1Amity Institute of Pharmacy, Amity University, Sector-125, Noida, Uttar Pradesh-201303.
2of , University , - , , - .

Tóm tắt

Nanoparticles (NPs) have been found to be potential targeted and controlled release drug delivery systems. Various drugs can be loaded in the NPs to achieve targeted delivery. Chitosan NPs being biodegradable, biocompatible, less toxic and easy to prepare, are an effective and potential tool for drug delivery. Chitosan is natural biopolymer which can be easily functionalized to obtain the desired targeted results and is also approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration [US FDA]). Various methods for preparation of chitosan NPs include, ionic cross-linking, covalent cross-linking, reverse micellar method, precipitation and emulsion-droplet coalescence method. Chitosan NPs are found to have plethora of applications in drug delivery diagnosis and other biological applications. The key applications include ocular drug delivery, per-oral delivery, pulmonary drug delivery, nasal drug delivery, mucosal drug delivery, gene delivery, buccal drug delivery, vaccine delivery, vaginal drug delivery and cancer therapy. The present review describes the formation of chitosan, synthesis of chitosan NPs and their various applications in drug delivery.

Từ khóa


Tài liệu tham khảo

10.1.1.460.1550

10.3390/md8072117

10.1208/pt070250

10.1016/j.jconrel.2004.08.010

10.1248/cpb.58.1423

Soutter W. Chitosan Nanoparticles – Properties and applications. 2nd ed. AZoNano; 2013.

10.3390/pharmaceutics9040053

10.1016/j.nano.2009.04.007

10.1080/10717540590889781

10.1023/a:1018995124527

10.3109/10611860903508788

10.3797/scipharm.1001-06

10.1016/j.carbpol.2016.04.115

10.2174/2210681206666160402003316

10.1016/j.coche.2015.11.006

Sailaja AK, 2010, Chitosan nanoparticles as a drug delivery system, Res J Pharm Biol Chem Sci, 1, 474

10.1023/A:1012160102740

10.1016/j.ijpharm.2015.06.021

10.1016/j.ijbiomac.2016.06.015

10.1016/s2213-2600(13)70072-9

10.1039/c6nr03256g

10.1016/j.colsurfb.2017.03.044

10.1016/j.powtec.2012.01.045

10.1208/s12249-018-0972-9

10.1371/journal.pone.0190976

10.1016/j.jconrel.2014.05.003

10.1016/S0168-3659(02)00363-2

10.1016/j.ajps.2017.09.001

10.1016/j.ijpharm.2012.02.044

10.1080/107175400455173

10.1042/0264-6021:3480557

10.1016/S0378-5173(99)00030-7

10.1021/bm015548s

10.1023/a:1011092613951

10.1016/b978-0-12-800148-6.00011-0

10.1007/s11095-006-9570-8

10.1016/j.biomaterials.2014.02.006

10.1016/j.carbpol.2016.04.041

10.1016/S0168-3659(03)00126-3

10.1016/j.addr.2006.03.006

10.1021/bc800428y

10.1016/j.biomaterials.2005.09.036

10.1038/sj.gt.3302838

10.1038/sj.mt.6300326

10.1016/j.jconrel.2008.02.004

10.1002/jgm.1370

10.2174/156720111796642336

10.1016/j.jcis.2012.04.058

10.1007/s12010-015-1483-8

10.2174/138161210790883778

10.1016/S0168-3659(01)00269-3

10.1002/jps.24142

10.1016/S0264-410X(00)00248-6

10.1016/S0939-6411(99)00026-0

10.1016/S0169-409X(01)00171-5

10.1038/7385

10.1016/j.fsi.2007.12.004

10.1016/S0928-0987(01)00172-5

10.3109/10717544.2014.908427

10.2217/nnm-2016-0291

10.1016/j.jconrel.2014.04.033

10.1517/17425247.2014.924499

10.1016/j.jconrel.2004.11.034

10.1089/jwh.2004.13.834

10.1016/j.carbpol.2017.04.051

10.3390/pharmaceutics10010023

10.1016/j.ejps.2017.11.029

10.1016/j.molonc.2014.08.013

10.1016/j.canlet.2014.09.017

10.1016/j.carbpol.2017.03.031

10.1016/j.jiec.2018.01.001

10.2217/nnm.14.99

10.1016/j.actbio.2016.09.045

10.1038/nrd.2015.17

10.1016/j.jconrel.2008.01.013